
AI
OpenEvidence AI startup hits $15B valuation as US doctors use tool
The ad-supported medical AI platform has reached a $15 billion valuation after nearly two-thirds of US physicians began using its chatbot.
Everything Threat Times has reported about OpenEvidence: 2 stories, newest first. Part of our AI coverage.

The ad-supported medical AI platform has reached a $15 billion valuation after nearly two-thirds of US physicians began using its chatbot.

The ad-supported medical chatbot claims high adoption among US doctors, with projections suggesting significant future revenue from its commercial model.